Mardia Samyoung Capillary Tubes Co Board of Directors

Get the latest insights into the leadership at Mardia Samyoung Capillary Tubes Co. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Dhaval Joshi Managing Director & CFO
Mr. Keyur Saxsena Non Executive Director
Mr. Sonal Vaghela Independent Director
Mr. Jaykumar Bhaveshkumar Patel Independent Director

Mardia Samyoung Capillary Tubes Co Share price

MSCTC

90

0.00 (0.00%)
Last updated on 14 Oct, 2025 | 14:15 IST
BUYSELL
Today's High

90.00

Today's Low

90.00

52 Week Low

7.59

52 Week High

90.00

The current prices are delayed, login to your account for live prices

Mardia Samyoung Capillary Tubes Co FAQs

The board at Mardia Samyoung Capillary Tubes Co consists of experienced professionals, including Mr. Dhaval Joshi , Mr. Keyur Saxsena , and others, overseeing the company’s strategic and corporate governance.

Directors at Mardia Samyoung Capillary Tubes Co are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Dhaval Joshi is the current chairman at Mardia Samyoung Capillary Tubes Co.

Executive directors at Mardia Samyoung Capillary Tubes Co are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Mardia Samyoung Capillary Tubes Co adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Mardia Samyoung Capillary Tubes Co, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.